354 related articles for article (PubMed ID: 30854133)
1. Overexpression of FZD1 is Associated with a Good Prognosis and Resistance of Sunitinib in Clear Cell Renal Cell Carcinoma.
Peng Q; Wang L; Zhao D; Lv Y; Wang H; Chen G; Wang J; Xu W
J Cancer; 2019; 10(5):1237-1251. PubMed ID: 30854133
[TBL] [Abstract][Full Text] [Related]
2. Low neighbor of Brca1 gene expression predicts poor clinical outcome and resistance of sunitinib in clear cell renal cell carcinoma.
Xiao W; Xiong Z; Yuan C; Bao L; Liu D; Yang X; Li W; Tong J; Qu Y; Liu L; Xiao H; Yang H; Zhang X; Chen K
Oncotarget; 2017 Nov; 8(55):94819-94833. PubMed ID: 29212269
[TBL] [Abstract][Full Text] [Related]
3. ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients.
Lu X; Wan F; Zhang H; Shi G; Ye D
Tumour Biol; 2016 Jan; 37(1):253-62. PubMed ID: 26198048
[TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
5. Caspase 4 Overexpression as a Prognostic Marker in Clear Cell Renal Cell Carcinoma: A Study Based on the Cancer Genome Atlas Data Mining.
Meng L; Tian Z; Long X; Diao T; Hu M; Wang M; Zhang W; Zhang Y; Wang J; He Y
Front Genet; 2020; 11():600248. PubMed ID: 33584797
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma.
Mu Z; Dong D; Sun M; Li L; Wei N; Hu B
Front Oncol; 2020; 10():1566. PubMed ID: 33102202
[TBL] [Abstract][Full Text] [Related]
8. ALDOB represents a potential prognostic biomarker for patients with clear cell renal cell carcinoma.
Shao Y; Wu B; Yang Z; Liu Z; Ma Y; Huang H; Liu Y; Wang Z; Hu W; Wang Y; Niu Y
Transl Androl Urol; 2023 Apr; 12(4):549-571. PubMed ID: 37181232
[TBL] [Abstract][Full Text] [Related]
9. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
[TBL] [Abstract][Full Text] [Related]
10. RCAN1.4 acts as a suppressor of cancer progression and sunitinib resistance in clear cell renal cell carcinoma.
Song Z; Cao Q; Ruan H; Yang H; Wang K; Bao L; Cheng G; Xu T; Xiao H; Wang C; Liu D; Chen K; Zhang X
Exp Cell Res; 2018 Nov; 372(2):118-128. PubMed ID: 30267660
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma.
Wang Y; Cong R; Liu S; Zhu B; Wang X; Xing Q
Cancer Cell Int; 2021 Jan; 21(1):46. PubMed ID: 33430867
[TBL] [Abstract][Full Text] [Related]
13. Identification of MX2 as a Novel Prognostic Biomarker for Sunitinib Resistance in Clear Cell Renal Cell Carcinoma.
Wei Y; Chen X; Ren X; Wang B; Zhang Q; Bu H; Qian J; Shao P
Front Genet; 2021; 12():680369. PubMed ID: 34306023
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis.
Fu Y; Sun S; Man X; Kong C
PeerJ; 2019; 7():e7854. PubMed ID: 31592165
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of caveolin-1 possesses diagnostic and prognostic value and promotes cell migration, invasion and sunitinib resistance in the clear cell renal cell carcinoma.
Ruan H; Li X; Yang H; Song Z; Tong J; Cao Q; Wang K; Xiao W; Xiao H; Chen X; Xu G; Bao L; Xiong Z; Yuan C; Liu L; Qu Y; Hu W; Gao Y; Ru Z; Chen K; Zhang X
Exp Cell Res; 2017 Sep; 358(2):269-278. PubMed ID: 28684115
[TBL] [Abstract][Full Text] [Related]
16.
Wang B; Liu B; Luo Q; Sun D; Li H; Zhang J; Jin X; Cheng X; Niu J; Yuan Q; Chen Y
Transl Cancer Res; 2022 Jul; 11(7):2321-2337. PubMed ID: 35966310
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of TXNIP predicts poor prognosis in patients with clear cell renal cell carcinoma.
Gao Y; Qi JC; Li X; Sun JP; Ji H; Li QH
Oncol Lett; 2020 Jan; 19(1):763-770. PubMed ID: 31897192
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma.
Büttner F; Winter S; Rausch S; Hennenlotter J; Kruck S; Stenzl A; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M; Schaeffeler E
BMC Med; 2018 Jul; 16(1):108. PubMed ID: 29973214
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database.
Xiao GF; Yan X; Chen Z; Zhang RJ; Liu TZ; Hu WL
Front Genet; 2020; 11():810. PubMed ID: 33014010
[TBL] [Abstract][Full Text] [Related]
20. The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
Xu WH; Shi SN; Wang J; Xu Y; Tian X; Wan FN; Cao DL; Qu YY; Zhang HL; Ye DW
Med Sci Monit; 2019 Dec; 25():9458-9470. PubMed ID: 31825950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]